Venture Capitalists Step Up Investment in Services
As products from technology-driven start-ups increasingly fail to gain support from customers and investors, VCs are steering more of their life sciences funds towards services. The withdrawal from technology , however, is more like a fire drill than a stampede, owing to the non-proprietary nature of medical service businesses. Yet the inefficiencies in US health care beg for solutions and VCs plan to oblige--largely by proferring information systems.
You may also be interested in...
The Independent Beauty Association’s Akemi Ooka, head of global supply chain resources, and new board chair Elizabeth Corrigan sat down with HBW Insight to discuss ongoing supply chain challenges, how the trade association’s members are adapting, and prospects for relief ahead.
International Flavors & Fragrances looks for CEO to replace Andreas Fibig; Ultrahuman Healthcare appoints private equity expert as business chief; prebiotics developer Clasado taps nutritional scientist; Abbott kicks off nutritional partnership with Real Madrid; and CRN adjusts membership fees.
Execs told Scrip they hope to get Tyrvaya (varenicline) onto formularies and aim for pricing that would make its nasal spray competitive with Restasis and Xiidra.